title: Perioperative supplementation of EPA reduces immunosuppression induced by postoperative chemoradiation therapy in patients with esophageal cancer.
authors.forename: K
authors.initials: K
authors.lastname: Takagi
authors.forename: H
authors.initials: H
authors.lastname: Yamamori
authors.forename: K
authors.initials: K
authors.lastname: Furukawa
authors.forename: M
authors.initials: M
authors.lastname: Miyazaki
authors.forename: T
authors.initials: T
authors.lastname: Tashiro
mesh_terms: D004537:Eicosanoic Acids / Q000494:pharmacology* / Q000627:therapeutic use; D004938:Esophageal Neoplasms / Q000276:immunology* / Q000532:radiotherapy / Q000628:therapy; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects* / Q000528:radiation effects; D007111:Immunity, Cellular / Q000187:drug effects; D019990:Perioperative Care; D018714:Radiotherapy, Adjuvant / Q000009:adverse effects; D012189:Retrospective Studies
chemical_list: D004537:Eicosanoic Acids